Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses
Corbella, E.; Garghetti, L.; Poloniato, A.; Zambelloni, C.; Consonni, A.
Minerva Pediatrica 39(20): 821-826
1987
ISSN/ISBN: 0026-4946 PMID: 2963953 Document Number: 286463
Document emailed within 1 workday
Related Documents
Saffar, M.J.; Rezai, M.S. 2004: Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth Indian Pediatrics 41(12): 1232-1237Faingezicht, I.; Avila-Aguerro, M.L.; Cervantes, Y.; Fourneau, M.; Clemens, S.A.C. 2002: Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Revista Panamericana de Salud Publica 12(4): 247-257
Schiff, G.M.; Sherwood, J.R.; Zeldis, J.B.; Krause, D.S. 1995: Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 16(1): 12-17
Salama, I.I.; Sami, S.M.; Salama, S.I.; Foud, W.A.; Abdel Hamid, A.T.; Said, Z.N. 2014: Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt Egyptian Journal of Immunology 21(1): 13-26
Chen, Y.-d.; Liang, X.-f.; Yao, J.; Cui, F.-q.; Li, Q.; Jiang, Z.-g.; Wang, F.-z.; Fang, C.-f.; Chen, R.-f.; Su, M.-f.; Zheng, X.-h. 2011: Evaluation on the efficacy of recombinant hepatitis B vaccine booster immunization in 2789 children aged over 10 years Zhonghua Liu Xing Bing Xue Za Zhi 32(3): 252-255
Milne, A.; Moyes, C.D.; Waldon, J.; Pearce, N.E.; Krugman, S. 1989: Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses New Zealand Medical Journal 102(874): 429-430
Liu, K.Z. 1989: A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen Zhonghua Yu Fang Yi Xue Za Zhi 23(3): 132-134
Chan, S.H.; Tan, P.T.N.; Han, H.H.; Bock, H.L. 2006: Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults Singapore Medical Journal 47(4): 286-290
Moyes, C.; Milne, A. 1988: Immunogenicity of a recombinant yeast-derived hepatitis B vaccine (Engerix B) in children New Zealand Medical Journal 101(843): 162-164
Lee, C.Y.; Huang, L.M.; Lee, P.I.; Chiu, H.H.; Dumas, R.; Milcamps, B.; Lin, W. 2000: Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children Southeast Asian Journal of Tropical Medicine and Public Health 31(1): 29-36
Hoffmann, F. 1979: Vaccinia antibody booster through MVA-vaccine in smallpox revaccination Münchener Medizinische Wochenschrift 121(27): 913-914
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157
Carlsson, R.-M.; Ekholm, L.; Gothefors, L.; Granström, M.; Trolin, I.; Tegnell, A. 2005: Time for booster doses against whooping cough for 10-year-old children Lakartidningen 102(35): 2394-2398
Wang, X.; Ma, J.; Zhang, Y.; Zhang, Y.; Han, C.; Xing, Z.; Chen, J.; Zhang, Y.; Zhao, S.; Gu, H.; Xu, Z. 2000: Primary study on immunologic effect of live attenuated hepatitis a vaccine (H2 strain) after booster dose Zhonghua Liu Xing Bing Xue Za Zhi 21(2): 124-127
Juszczyk, J.; Barałkiewicz, G. 1992: Long term results of vaccination against viral hepatitis B using recombinant vaccine Engerix B Przeglad Epidemiologiczny 46(4): 271-279
Liang, Z.; Li, C.; Jing, Q. 1998: Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children Zhonghua Yu Fang Yi Xue Za Zhi 32(3): 165-167
Young, B.W.Y.; Lee, S.S.; Lim, W.L.; Yeoh, E.K. 2003: The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers Journal of Viral Hepatitis 10(1): 23-30
Jafarzadeh, A.; Montazerifar, S.J. 2006: Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth Journal of Ayub Medical College Abbottabad: Jamc 18(4): 4-9
Xia, G.; Jia, Z.; Yan, T.; Li, R.; Liu, H.; Xu, Z.; Cao, H.; Liu, C. 2002: Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(2): 146-149
Ferreira, C.R.; Yoshida, C.F.; Mercadante, L.A.; Gomes, D.F.; Oliveira, J.M.; França, M.S.; Sidoni, M.; Ennes, I.C.; Baptista, M.L.; Schatzmayr, H.G. 1993: Immunization against hepatitis B in children from endemic zone: evaluation of the antibody response against the DNA recombinant vaccine (Engerix B-20 MCG) Revista do Instituto de Medicina Tropical de Sao Paulo 35(1): 89-92